Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Balaji AminesNSE:BALAMINES -1.23%75 EV-to-EBIT is 24.73 as of Jul. 31, 2026, which is 38% above its 10-year median of 17.95. GuruFocus rates NSE:BALAMINES with a GF Score™ of 75/100 and a GF Value™ of ₹1,790.61 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 1,240 Chemicals companies, Balaji Amines ranks worse than 64.52% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Balaji Amines's Enterprise Value for the quarter that ended in Jun. 2026 was ₹65,965 Mil.
Balaji Amines's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2,957 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Balaji Amines EV-to-EBIT Related Terms
Balaji Amines EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Balaji Amines's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:BALAMINES vs LIN, SHW, ECL: EV-to-EBIT Comparison
For the Specialty Chemicals subindustry, Balaji Amines's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Balaji Amines EV-to-EBIT vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Balaji Amines's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Balaji Amines's EV-to-EBIT falls into.
Balaji Amines's current Enterprise Value is ₹73,149 Mil.
Balaji Amines's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2,957 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Balaji Amines (NSE:BALAMINES) has a EV-to-EBIT of 24.73 as of Jul. 31, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Balaji Amines and its competitors. This is 38% above median its historical median of 17.95. Over the past decade, Balaji Amines' EV-to-EBIT has ranged from 4.60 to 38.27. According to the industry distribution chart, Balaji Amines ranks #800 out of 1240 companies in the Chemicals industry, placing it in the top 64.5%.
Is Balaji Amines' EV-to-EBIT too high?
Balaji Amines' current EV-to-EBIT of 24.73 is 38% above median its 10-year median of 17.95. Over the past 10 years, this metric has ranged from a low of 4.60 to a high of 38.27. The Chemicals industry median EV-to-EBIT is 16.90. Balaji Amines' value of 24.73 is 46.3% above this industry median. Based on the distribution chart, Balaji Amines ranks #800 out of 1240 companies in the Chemicals industry, which is below the industry midpoint. Overall, Balaji Amines has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Balaji Amines' EV-to-EBIT compare to LIN and SHW?
According to the Chemicals industry distribution chart, Balaji Amines ranks #800 out of 1240 companies for EV-to-EBIT. This places Balaji Amines in the lower half of its industry. The industry median EV-to-EBIT is 16.90. Balaji Amines' value of 24.73 is 46.3% above this benchmark. Historically, Balaji Amines' own EV-to-EBIT has ranged from 4.60 to 38.27 over the past decade. While the company's 10-year median is 17.95 vs. the industry median of 16.90, Balaji Amines has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Chemicals company?
The median EV-to-EBIT among Chemicals companies is 16.90, based on 1,240 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Balaji Amines's current EV-to-EBIT of 24.73 is 46.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Balaji Amines and its competitors. For the Chemicals industry, the median EV-to-EBIT is 16.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Balaji Amines's current EV-to-EBIT is 24.73, which is 38% above median its own 10-year median of 17.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Balaji Amines stock overvalued right now?
Based on GuruFocus' analysis, Balaji Amines (NSE:BALAMINES) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,790.61, compared to a current price of ₹2,243.40 — trading 25.3% above its estimated fair value. The current EV-to-EBIT is 24.73, which is 38% above median its 10-year median of 17.95 and 46.3% above the Chemicals industry median of 16.90. Balaji Amines' overall GF Score™ is 75/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Balaji Amines (NSE:BALAMINES), the current EV-to-EBIT is 24.73 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Balaji Amines (NSE:BALAMINES) Overvalued in 2026?
Based on GuruFocus' analysis, Balaji Amines stock appears to be overvalued.
The current stock price of ₹2,243.40 is trading 25.3% above its estimated GF Value™ of ₹1,790.61.
GuruFocus considers Balaji Amines to be Modestly Overvalued.
Key valuation signals for NSE:BALAMINES:
EV-to-EBIT: 24.73 (38% above median its 10-year median of 17.95)
GF Value™: ₹1,790.61 vs. price of ₹2,243.40 (25.3% above fair value)
Industry Position: 46.3% above the Chemicals median (#800 of 1240)
No single metric tells the full story. See the NSE:BALAMINES stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Balaji Amines Ltd is engaged in the manufacture and sale of aliphatic amines, speciality chemicals, and their derivatives. The Company's manufacturing facilities operate through Distributed Control Systems (DCS), indigenous process technologies, and a Zero Liquid Discharge (ZLD) framework. The business operates through the Chemicals and Hotel segments, with the Chemicals segment generating maximum revenue. Its products include amines such as Mono Methyl Amine (MMA), Di-Methyl Amine (DMA) and others; speciality chemicals such as Morpholine, Acetonitrile (ACN), and others; and amine derivatives such as Mono-Methyl Amine Hydrochloride (MMA HCL), Di-Methyl Amine Hydrochloride (DMA HCL) and others. Geographically, the Company generates maximum revenue from India.
75GF Score
Get the complete analysis for NSE:BALAMINES
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:BALAMINES has been successfully added to your 
